Two men charged over counterfeit Ozempic smuggled from China

Two men charged over counterfeit Ozempic smuggled from China

On September 29, 2026, the U.S. Attorney’s Office for the Middle District of Florida and the Justice Department’s Criminal Division announced conspiracy and smuggling charges against Swapnadip Roy and Vicky Ramancha, both Indian nationals, with the FDA’s Office of Criminal Investigations assisting. The indictment alleges that between July 2023 and April 2024 they obtained counterfeit … Read more

Lilly files six lawsuits over black-market retatrutide sales

Lilly files six lawsuits over black-market retatrutide sales

Eli Lilly filed six lawsuits on 12 August 2026 against US entities selling black-market retatrutide, an investigational molecule in Phase 3 trials that no regulator has approved for human use. The defendants are Aesthetic Envy Cosmetic Centers, Astra Peptides, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide: compounding pharmacies, medical spas and online … Read more

Court declines to force tirzepatide back onto the shortage list

Court declines to force tirzepatide back onto the shortage list

The US District Court for the Northern District of Texas denied the Outsourcing Facilities Association’s motion for a preliminary injunction, which had sought to prevent the FDA from keeping tirzepatide off the drug shortage list. Consequential for the compounding market: shortage status is the legal basis for much large-scale compounding of a drug, so the … Read more